Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SB-334867 free base (SB334867A free base) is a selective orexin-1 (OX1) receptor antagonist.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 32.00 | |
2 mg | In stock | $ 45.00 | |
5 mg | In stock | $ 68.00 | |
10 mg | In stock | $ 105.00 | |
25 mg | In stock | $ 221.00 | |
50 mg | In stock | $ 387.00 | |
100 mg | In stock | $ 576.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 68.00 |
Description | SB-334867 free base (SB334867A free base) is a selective orexin-1 (OX1) receptor antagonist. |
Targets&IC50 | OXB:100 nM, OXA:10 nM |
In vitro | In CHO-OX1 cells, SB-334867 inhibits the orexin-A (10 nM) and orexin-B (100 nM)-induced calcium responses with pKB of 7.27 and 7.23 respectively, without effect on the UTP (3 microM)-induced calcium response. [1] |
In vivo | In both male and female rats, SB-334867 (30 mg/kg, i.p.) significantly reduces natural and orexin-A-induced food intake. [2] SB-334867 (2 mg/kg, i.v.) blocks the effects of antipsychotic drugs on dopamine neuronal activity in rats. [3] SB-334867 also inhibits the development of morphine analgesic tolerance in rats. [4] |
Synonyms | SB334867A free base, SB-334867, SB 334867, SB334867 |
Molecular Weight | 319.32 |
Formula | C17H13N5O2 |
CAS No. | 792173-99-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 3.2 mg/mL (10 mM)), Heating is recommended.
DMSO: 31.9 mg/mL (100 mM), Heating is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SB-334867 free base 792173-99-0 GPCR/G Protein Neuroscience OX Receptor CHO SB334867A free base BEC ethanol intake SB-334867 SB334867 free base sucrose Hypocretin Receptor locomotor cell SB 334867 activity SB334867A SB334867 Orexin Receptor (OX Receptor) SB 334867 free base HCRT Receptor inhibit Inhibitor inhibitor